Argenx
ARGX
#558
Rank
C$48.13 B
Marketcap
$789.26
Share price
-5.92%
Change (1 day)
50.85%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of December 2024 : C$7.81 Billion

According to Argenx 's latest financial reports the company has C$7.81 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$C$7.88 B45.18%
2023-12-31$C$5.43 B42.34%
2022-12-31$C$3.81 B18.22%
2021-12-31$C$3.22 B23.02%
2020-12-31$C$2.62 B52.02%
2019-12-31$C$1.72 B79.95%
2018-12-31$C$0.95 B53.74%
2017-12-31$C$0.62 B562.59%
2016-12-31$C$94.21 M52.4%
2015-12-31$C$61.81 M-28.08%
2014-12-31$C$85.95 M95.08%
2013-12-31$C$44.06 M101.16%
2012-12-31$C$21.9 M-40.57%
2011-12-31$C$36.85 M170.88%
2010-12-31$C$13.6 M